Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Applied Therapeutics (APLT) Current Assets (2023 - 2025)

Historic Current Assets for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $31.7 million.

  • Applied Therapeutics' Current Assets fell 6973.89% to $31.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year decrease of 6973.89%. This contributed to the annual value of $83.6 million for FY2024, which is 5380.06% up from last year.
  • Latest data reveals that Applied Therapeutics reported Current Assets of $31.7 million as of Q3 2025, which was down 6973.89% from $34.5 million recorded in Q2 2025.
  • In the past 5 years, Applied Therapeutics' Current Assets ranged from a high of $150.9 million in Q1 2024 and a low of $29.1 million during Q1 2023
  • In the last 3 years, Applied Therapeutics' Current Assets had a median value of $54.0 million in 2025 and averaged $68.9 million.
  • In the last 5 years, Applied Therapeutics' Current Assets soared by 41923.75% in 2024 and then plummeted by 7294.78% in 2025.
  • Quarter analysis of 3 years shows Applied Therapeutics' Current Assets stood at $54.4 million in 2023, then surged by 53.8% to $83.6 million in 2024, then crashed by 62.16% to $31.7 million in 2025.
  • Its Current Assets stands at $31.7 million for Q3 2025, versus $34.5 million for Q2 2025 and $54.0 million for Q1 2025.